DNDI asaq
How You Can Help
Every day, over 35,000 people die from AIDS, malaria, tuberculosis, and most neglected diseases such as kala azar, Chagas disease, and sleeping sickness. They die needlessly. Huge advances in science and technology have helped reduce the infectious disease burden in developed nations. But for the poor and neglected, the current model of drug development has not brought the hope of new medicines and diagnostics. The only drugs available to them are ineffective, unaffordable, and often toxic. DNDi works to develop new drugs or new formulations of existing drugs for patients suffering from the most neglected communicable diseases. DNDi’s success depends on the generous support from foundations, governments and individuals. Join DNDi and its partners! Make a secure donation online through Paypal.




Please note that donations are only tax deductible for Swiss residents at this time.

To find out how to support one short-term project, a part of the portfolio of projects for a specific disease, or the initiative itself, please contact our fundraising manager:
Jennifer Katz
+ 41.22.906.9240
supportdndi@dndi.org
Version française English version
asaq asaq
contents
 
Updates
Press release
Sanofi-aventis Wins the 2010 Global Business Coalition Core Competence Award
New, Once-a-Day Fixed-Dose Combination Against Malaria
Videos
ASAQ in a few words
ASAQ product profile
ASAQ... Adapted
ASAQ...Simple
ASAQ... Accessible
ASAQ... Quality
Clinical Data
An innovative partnership
ASAQ: Contribution of DNDi
and FACT Partners
ASAQ: Contribution of sanofi-aventis
DNDi: addressing the therapeutic needs of the most neglected
sanofi-aventis
Background on malaria
ASAQ in the media
Governments welcome ASAQ!ItalyGermanyEuropean UnionUnited KingdomNetherlands
MSF welcomes ASAQ
Current activities on the field
sanofi-aventis partners with National Malaria Control Programmes An innovative partnership between sanofi-aventis and the NGO "Jeremi" in Burkina Faso"Schoolchildren against malaria": raising awareness through drama
plos
Read the PLoS guest blog of Jean-René Kiechel & Bernard Pecoul:
"Innovative Partnership Brings New ACT Free of Patent"
Original FACT Partners
(who signed onto the original EU INCO-DEV grant in 2002):
Instituto de Tecnologia em Farmacos of Farmanguinhos Centre National de Recherche et de Formation sur le Paludisme (CNRFP) Mahidol University Médecins Sans Frontières UNICEF-UNDP-World Bank-WHO's Special Programme for Research and Training in Tropical Diseases (TDR) Université Victor Segalen Bordeaux II (TROPIVAL) University of Oxford University Sains Malaysia Since the main FACT partners formed in 2002, many additional partners are contributing to this project.read more
Links of related interest: London School of Hygiene & Tropical Medicine Malaria Consortium Medicines for Malaria Venture (MMV) MSF Access President's Malaria Initiative Roll Back Malaria UNITAID WHO Global Malaria Programme (GMP)
asaq